Credelio from Elanco Animal Health Inc. - soft chew once a month against ticks and fleas

Reviewed: ad hoc news New Release & Launch desk. Edited and checked on 2026-06-23, 03:11. Details in the imprint.

Credelio from Elanco Animal Health Inc. disappears in a dog’s mouth with a quick crunch, leaving only a faint meaty smell on your fingers and the quiet relief that ticks and fleas are sorted for another month.

What Credelio actually does

Credelio is an oral parasiticide for dogs that targets fleas and several common tick species using the active ingredient lotilaner. It is given once a month as a chewable tablet and is available in different strengths based on body weight.

Veterinarians appreciate that Credelio starts killing fleas within hours of administration and maintains protection for a full month when dosed correctly. Compared with topical spot-ons, the oral route means no greasy fur patches and no waiting before petting or bathing.

How it feels in daily use

Product manager Kristin Peck from Elanco has highlighted in presentations that owners often prefer small, flavored tablets because dosing becomes part of a short treat ritual instead of a wrestling match on the bathroom floor. Many dogs take Credelio voluntarily, which reduces stress for both sides.

In practice, the tablet is compact and has a slightly rough surface that does not slip from wet fingers. You hear a clear crunch when the dog bites down, but the process is over in seconds and there is no residue on the coat or on cushions.

Spectrum, dosing and limits

Credelio is typically indicated for dogs at least 8 weeks of age and above a minimum body weight, with tablets color coded for the corresponding weight range. The monthly dosing schedule demands a steady routine, otherwise the protection window may open up.

The product focuses on fleas and ticks and does not replace deworming or heartworm prevention. For dogs in high-risk areas, veterinarians often combine Credelio with additional treatments, which can increase the total annual cost of parasite control for owners.

How veterinarians and owners see it

In clinics, Credelio positions itself against other oral flea and tick products by offering a compact tablet and a once-a-month schedule rather than longer acting but less flexible doses. For some owners, the ability to stop or switch after a month is an advantage when side effects occur.

Feedback from dog owners in online reviews often mentions the tidy look of the coat after switching from topical spot-ons and the convenience of giving a chew at the kitchen table instead of applying a pipette on the neck.

Market role and stock angle

Within Elanco, Credelio belongs to the companion animal segment, which management regularly highlights as a key contributor to margin improvement alongside newer parasiticide launches. Analysts follow prescription trends in this portfolio as a proxy for the company’s competitive position.

All told, Elanco Animal Health Inc. shares are listed on the New York Stock Exchange under the ticker ELAN, giving investors direct exposure to recurring revenue streams from products such as Credelio.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.